High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study
Authors:
- G YimerGYG Yimer
- W AmogneWAW Amogne
- A HabtewoldAHA Habtewold
- E MakonnenEME Makonnen
- N UedaNUN Ueda
- A SudaASA Suda
- A WorkuAWA Worku
- W E HaefeliWHW E Haefeli
- J BurhenneJBJ Burhenne
- G AderayeGAG Aderaye
- L LindquistLLL Lindquist
- E AklilluEAE Aklillu
- 23 August 2011
- journal article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 12 (6) , 499-506
Abstract
The Pharmacogenomics Journal is dedicated to the rapid publication of original research on basic pharmacogenomics research and its clinical applications.Keywords
This publication has 37 references indexed in Scilit:
- Effect ofCYP2B6,ABCB1, andCYP3A5Polymorphisms on Efavirenz Pharmacokinetics and Treatment Response: An AIDS Clinical Trials Group StudyThe Journal of Infectious Diseases, 2010
- Haplotype structure of CYP2B6 and association with plasma efavirenz concentrations in a Chilean HIV cohortJournal of Antimicrobial Chemotherapy, 2010
- Enhanced oxidative stress and increased mitochondrial mass during Efavirenz‐induced apoptosis in human hepatic cellsBritish Journal of Pharmacology, 2010
- Presence of the CYP2B6 516G> T polymorphism, increased plasma Efavirenz concentrations and early neuropsychiatric side effects in South African HIV-infected patientsAIDS Research and Therapy, 2010
- A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single‐dose efavirenz population pharmacokinetics in UgandansBritish Journal of Clinical Pharmacology, 2009
- CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patientsAIDS, 2009
- Hepatotoxicity of AntiretroviralsDrug Safety, 2005
- Hepatotoxicity of Nucleoside Reverse Transcriptase InhibitorsSeminars in Liver Disease, 2003
- Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infectionsHepatology, 2002
- Criteria of drug-induced liver disordersJournal of Hepatology, 1990